FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Vaccine | rheumatoid arthritis

Vaccine cure for RA heads to human trial

Tools
  • Email
  • Print
  • Comment
  • Contact Author
  • Reprint

A team of scientists at Newcastle University is preparing a small human trial to test a one-shot approach to curing rheumatoid arthritis with a vaccine devised from a patient's white blood cells. The cells are taken from the volunteers and manipulated with a recipe of chemicals, steroids and Vitamin D so they can suppress the immune system rather than spur it. And a single jab could be enough to suppress the auto-immune response that triggers rheumatoid arthritis.

"This is an important potential cure. It is possible one injection could switch off the abnormal immune response," Prof Alan Silman, medical director of the charity Arthritis Research Campaign, which funded the research, told the Telegraph. "If it works it could reverse the disease and stop further episodes."

If they are successful, the researchers believe that a one-shot approach to treating RA would be worth a considerable amount of money to patients. Silman said the vaccine would be sold in the UK for less than £25,000.

- here's the release
- read the report from the Telegraph

Related Articles:
Scientists unveil new pathway for rheumatoid arthritis
Gene therapy study relieves pain in RA mice model

More stories about Vaccine   rheumatoid arthritis  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 12 + 1?
To combat spam, please solve the math question above.